Children’s Cancer Institute shared on LinkedIn:
“Three-year-old Tashy was a happy, energetic little girl who loved dancing, riding her bike and spending time with her siblings.
Then one winter, an illness left her pale, exhausted and feverish.
Her mum Kat, a paramedic, couldn’t shake the feeling that something wasn’t right.
After multiple hospital visits, more tests than the family could count and days spent waiting for answers, Kat received the phone call every parent fears: doctors believed Tashy had leukaemia.
On 10 September 2025, that diagnosis was confirmed.
Tashy had B-cell acute lymphoblastic leukaemia (ALL).
What followed was a whirlwind of chemotherapy, repeated hospital admissions, dangerous complications and months spent taking life one day, and sometimes one hour, at a time.
Today, Tashy is receiving maintenance therapy, but as her family has learned, childhood cancer doesn’t simply end when treatment becomes less intensive. The impact remains for the whole family.
As Kat says, ‘How could you ever call a cancer good? It’s a whole childhood that just vanishes, and you don’t get it back.’
Throughout Tashy’s treatment, research has provided answers, reassurance and hope for the future.
Now, Kat wants to see a world where children diagnosed after Tashy face kinder, safer and more effective treatments.
Read Tashy’s story and see why research matters for every child diagnosed with cancer: Tashy’s story.”
Other articles about acute lymphoblastic leukaemia on OncoDaily.
